Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Pharmacological antagonism of mineralocorticoid receptor exerts VEGF-independent anti-angiogenic effects: Implication for wet AMD

Francine F Behar-Cohen; Irmela Mantel; Emmanuelle Gelize; Carlo Rivolta; Jérémie Ganonica; Frederic Jaisser; Min Zhao

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):975. doi:

ARVO Annual Meeting Abstract July 2019

Mineralocorticoid receptor invalidation in vascular endothelial cells prevents CNV development

Min Zhao; Emmanuelle Gelize; Xinxin Li; Alejandro Arboleda; Jérémie Ganonica; Frederic Jaisser; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4911. doi:

ARVO Annual Meeting Abstract July 2019

Anti-angiogenic effect of Spironolactone on a model of corneal neovascularization

Clemence Bonnet; Min Zhao; Marie Seminel; Remi Dailleux; Emmanuelle Gelize; Jean Louis Bourges; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5406. doi:

ARVO Annual Meeting Abstract July 2018

Aquaporin 4 and glymphatic drainage in the human macula

Francine F Behar-Cohen; Alexandre Moulin; Laurent Jonet; Emmanuelle Gelize; Alexandre Sellam; Patricia Crisanti

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):388. doi:

ARVO Annual Meeting Abstract September 2016

Diabetes-induced ROCK activation contributes to outer blood retinal barrier breakdown: implications for diabetic macular edema

Pierre-Raphael Rothschild; Sawsen Salah; Emmanuelle Gelize; Ciara Bergin; Mariane Berdugo; Christophe Klein; Alexandre P Moulin; Michèle Savoldelli; Laurent Jonet; Francine F Behar-Cohen; Patricia Crisanti

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

Advertisement